Venus Remedies Limited

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange about a copy of newspaper publication.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company, with the Board of Directors approving certain revisions to the proposed alteration of the Memorandum of Association (MOA) and Articles of Association (AOA) to align with the Companies Act, 2013 and update business practices.

Venus Remedies Limited

Venus Remedies Limited has announced its unaudited financial results for the quarter ended June 30, 2026, along with the approval of certain revisions to the proposed alteration of the Memorandum of Association (MOA) and Articles of Association (AOA). The company has also placed the revised MOA before the members for approval at the ensuing 37th Annual General Meeting.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange regarding 'Social Media Post on KYC updation'. The company has posted on social media platforms to sensitize and encourage shareholders to update their KYC details.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, in compliance with Regulation 74(5) of the same regulations.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange regarding a social media post on awareness of physical shares. The post is about a special window for re-lodgement of transfer requests of physical shares in accordance with SEBI dated July 02, 2025 and 30th January 2026.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange about the publication of its AGM notice prior to the scheduled date.

Venus Remedies Limited

Venus Remedies Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.